CureVac (CVAC) Earnings Date & Reports

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CVAC is expected to report earnings to fall 34.78% to -15 cents per share on August 14

Q2'25

Est.

$-0.15

Q1'25

Missed

by $0.07

Q4'24

Beat

by $0.09

Q3'24

Beat

by $0.10

Q2'24

Missed

by $0.04

The last earnings report on May 20 showed earnings per share of -23 cents, missing the estimate of -16 cents. With 195.12K shares outstanding, the current market capitalization sits at 878.12M.

View a ticker or compare two or three

Compare

CVAC